Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 198208, 16 pages
http://dx.doi.org/10.1155/2010/198208
Review Article

Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches

Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA

Received 17 September 2009; Accepted 7 April 2010

Academic Editor: Rolf Bjerkvig

Copyright © 2010 James C. Marsh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Ewend, S. Elbabaa, and L. A. Carey, “Current treatment paradigms for the management of patients with brain metastases,” Neurosurgery, vol. 57, no. 5, pp. S66–S77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Mehta and D. Khuntia, “Current strategies in whole-brain radiation therapy for brain metastases,” Neurosurgery, vol. 57, no. 5, pp. S33–S44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. K. H. Peacock and G. J. Lesser, “Current therapeutic approaches in patients with brain metastases,” Current Treatment Options in Oncology, vol. 7, no. 6, pp. 479–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. N. Tsao, N. Lloyd, R. Wong, E. Chow, E. Rakovitch, and N. Laperriere, “Whole brain radiotherapy for the treatment of multiple brain metastases,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD003869, 2006. View at Google Scholar
  5. L. Gaspar, C. Scott, and C. Scott, “Recursive Partitioning Analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 4, pp. 745–751, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Kondziolka, A. Patel, L. D. Lunsford, A. Kassam, and J. C. Flickinger, “Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases,” International Journal of Radiation Oncology Biology Physics, vol. 45, no. 2, pp. 427–434, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Patchell, P. A. Tibbs, and P. A. Tibbs, “Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial,” Journal of the American Medical Association, vol. 280, no. 17, pp. 1485–1489, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. D. W. Andrews, C. B. Scott, and C. B. Scott, “Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial,” Lancet, vol. 363, no. 9422, pp. 1665–1672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. K. Sneed, J. H. Suh, and J. H. Suh, “A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 3, pp. 519–526, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. D. Roman and P. W. Sperduto, “Neuropsychological effects of cranial radiation: current knowledge and future directions,” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 4, pp. 983–998, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. L. M. DeAngelis, J.-Y. Delattre, and J. B. Posner, “Radiation-induced dementia in patients cured of brain metastases,” Neurology, vol. 39, no. 6, pp. 789–796, 1989. View at Google Scholar · View at Scopus
  12. J. Li, S. M. Bentzen, J. Li, M. Renschler, and M. P. Mehta, “Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis,” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 1, pp. 64–70, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. G. Welzel, K. Fleckenstein, J. Schaefer, B. Hermann, U. Kraus-Tiefenbacher, S. K. Mai, and F. Wenz, “Memory function before and after whole brain radiotherapy in patients with and without brain metastases,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 5, pp. 1311–1318, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. C. Paulino, C. B. Saw, and B.-C. Wen, “Comparison of posterior fossa and tumor bed boost in medulloblastoma,” American Journal of Clinical Oncology, vol. 23, no. 5, pp. 487–490, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Palmer, O. Goloubeva, and O. Goloubeva, “Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis,” Journal of Clinical Oncology, vol. 19, no. 8, pp. 2302–2308, 2001. View at Google Scholar · View at Scopus
  16. R. Nandagopal, C. Laverdière, D. Mulrooney, M. M. Hudson, and L. Meacham, “Endocrine late effects of childhood cancer therapy: a report from the children's oncology group,” Hormone Research, vol. 69, no. 2, pp. 65–74, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. I. T. Gavrilovic, A. Hormigo, J. Yahalom, L. M. DeAngelis, and L. E. Abrey, “Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma,” Journal of Clinical Oncology, vol. 24, no. 28, pp. 4570–4574, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. J. F. Lester, F. R. MacBeth, and B. Coles, “Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a cochrane review,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 3, pp. 690–694, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. Stuschke, W. Eberhardt, and W. Eberhardt, “Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects,” Journal of Clinical Oncology, vol. 17, no. 9, pp. 2700–2709, 1999. View at Google Scholar · View at Scopus
  20. M. Stuschke and C. Pöttgen, “Prophylactic cranial irradiation as a component of intensified initial treatment of locally advanced non-small cell lung cancer,” Lung Cancer, vol. 42, no. 2, pp. S53–S56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Pöttgen, W. Eberhardt, and W. Eberhardt, “Prophylactic cranial irradiation in operable stage IIIA non-small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial,” Journal of Clinical Oncology, vol. 25, no. 31, pp. 4987–4992, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. E. Topkan, B. A. Yildirim, U. Selek, and M. N. Yavuz, “Cranial prophylactic irradiation in locally advanced non-small cell lung carcinoma: current status and future perspectives,” Oncology, vol. 76, no. 3, pp. 220–228, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. E. Gore, “RTOG 0214: a phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer,” Clinical Advances in Hematology and Oncology, vol. 3, no. 8, pp. 625–626, 2005. View at Google Scholar · View at Scopus
  24. B. Movsas et al., “Phase III study of prophylactic cranial irradeiation (PCI) vs. observation in patients with stage III nonsmall-cell lung cancer (NSCLC): neurocognitive and quality of life (QOL): analysis of RTOG 0214,” ASTRO 2009; Abstract 2.
  25. D. J. Samson, J. Seidenfeld, G. R. Simon, A. T. Turrisi III, C. Bonnell, K. M. Ziegler, and N. Aronson, “Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition),” Chest, vol. 132, no. 3, pp. 324S–339S, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. C. Le Péchoux, A. Dunant, and A. Dunant, “Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial,” The Lancet Oncology, vol. 10, no. 5, pp. 467–474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Aupérin, R. Arriagada, and R. Arriagada, “Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission,” New England Journal of Medicine, vol. 341, no. 7, pp. 476–484, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Slotman, C. Faivre-Finn, and C. Faivre-Finn, “Prophylactic cranial irradiation in extensive small-cell lung cancer,” New England Journal of Medicine, vol. 357, no. 7, pp. 664–672, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. R. Arriagada, T. Le Chevalier, and T. Le Chevalier, “Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission,” Journal of the National Cancer Institute, vol. 87, no. 3, pp. 183–190, 1995. View at Google Scholar · View at Scopus
  30. B. J. Slotman, M. E. Mauer, and M. E. Mauer, “Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms-results of an international phase III randomized controlled trial by the EORTC radiation oncology and lung cancer groups,” Journal of Clinical Oncology, vol. 27, no. 1, pp. 78–84, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. C. H. Pui, “Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment,” Hematology. American Society of Hematology. Education Program, pp. 142–146, 2006. View at Google Scholar · View at Scopus
  32. J. T. Sandlund, C.-H. Pui, and C.-H. Pui, “Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study,” Leukemia, vol. 23, no. 6, pp. 1127–1130, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. Uyttebroeck, S. Suciu, and S. Suciu, “Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial,” European Journal of Cancer, vol. 44, no. 6, pp. 840–846, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. T. E. Merchant, E. N. Kiehna, and E. N. Kiehna, “Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 1, pp. 210–221, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. N. E. Cross and M. J. Glantz, “Neurologic complications of radiation therapy,” Neurologic Clinics, vol. 21, no. 1, pp. 249–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Welzel, A. Niethammer, U. Mende, S. Heiland, F. Wenz, J. Debus, and R. Krempien, “Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell lung cancer: first results of a prospective study,” American Journal of Neuroradiology, vol. 29, no. 2, pp. 379–383, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. P.-L. Khong, D. L. W. Kwong, G. C. F. Chan, J. S. T. Sham, F.-L. Chan, and G.-C. Ooi, “Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study,” American Journal of Neuroradiology, vol. 24, no. 4, pp. 734–740, 2003. View at Google Scholar · View at Scopus
  38. M. Bitzer and H. Topka, “Progressive cerebral occlusive disease after radiation therapy,” Stroke, vol. 26, no. 1, pp. 131–136, 1995. View at Google Scholar · View at Scopus
  39. T. Kondoh, A. Morishita, M. Kamei, Y. Okamura, M. Tamaki, and E. Kohmura, “Moyamoya syndrome after prophylactic cranial irradiation for acute lymphocytic leukemia,” Pediatric Neurosurgery, vol. 39, no. 5, pp. 264–269, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. Nishizawa, H. Ryu, T. Yokoyama, T. Ninchoji, I. Shimoyama, S. Yamamoto, and K. Uemura, “Post-irradiation vasculopathy of intracranial major arteries in children—report of two cases,” Neurologia Medico-Chirurgica, vol. 31, no. 6, pp. 336–341, 1991. View at Google Scholar · View at Scopus
  41. N. Ishikawa, C. Tajima, N. Yofune, S. Nishimura, and M. Kobayashi, “Moyamoya syndrome after cranial irradiation for bone marrow transplantation in a patient with acute leukemia,” Neuropediatrics, vol. 37, no. 6, pp. 364–366, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. D. A. Power, “Late effects of radiotherapy: how to assess and improve outcomes,” British Journal of Radiology, vol. 78, no. 926, pp. 150–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. E. J. Hall and A. J. Giaccia, Eds., Clinical Response of Normal Tissues, from Radiobiology for the Radiologist, chapter 19, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 6th edition, 2006.
  44. B. Emami, J. Lyman, and J. Lyman, “Tolerance of normal tissue to therapeutic irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 21, no. 1, pp. 109–122, 1991. View at Google Scholar · View at Scopus
  45. J. F. Fowler, “The linear-quadratic formula and progress in fractionated radiotherapy,” British Journal of Radiology, vol. 62, no. 740, pp. 679–694, 1989. View at Google Scholar · View at Scopus
  46. B. Borgelt, R. Gelber, S. Kramer et al., “The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group,” International Journal of Radiation Oncology Biology Physics, vol. 6, no. 1, pp. 1–9, 1980. View at Google Scholar · View at Scopus
  47. T. N. Byrne, “Cognitive sequelae of brain tumor treatment,” Current Opinion in Neurology, vol. 18, no. 6, pp. 662–666, 2005. View at Google Scholar · View at Scopus
  48. A. Gregor, A. Cull, and A. Cull, “Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell cancer: results of a multicentre randomised trial,” European Journal of Cancer, vol. 33, no. 11, pp. 1752–1758, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. T. A. Ahles, P. M. Silberfarb, J. Herndon et al., “Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with and without warfarin: a study by the Cancer and Leukemia Group B,” Journal of Clinical Oncology, vol. 24, pp. 1295–1304, 2006. View at Google Scholar
  50. W. F. Regine, C. Scott, K. Murray, and W. Curran, “Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04,” International Journal of Radiation Oncology Biology Physics, vol. 51, no. 3, pp. 711–717, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Komaki, C. A. Meyers, D. M. Shin, A. S. Garden, K. Byrne, J. A. Nickens, and J. D. Cox, “Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 33, no. 1, pp. 179–182, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. C. A. Meyers, J. A. Smith, and J. A. Smith, “Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial,” Journal of Clinical Oncology, vol. 22, no. 1, pp. 157–165, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. G. Welzel, K. Fleckenstein, S. K. Mai, B. Hermann, U. Kraus-Tiefenbacher, and F. Wenz, “Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors,” Strahlentherapie und Onkologie, vol. 184, no. 12, pp. 647–654, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. A. Kanard, S. Frytak, and A. Jatoi, “Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management,” Journal of Supportive Oncology, vol. 2, no. 2, pp. 127–140, 2004. View at Google Scholar · View at Scopus
  55. G. Baumann, B. Fisher, S. Schild et al., “Meningioma, ependymoma, and other adult brain tumors,” in Clinical Radiation Oncology, chapter 25, pp. 548–549, 554–556, 560–561, Churchill Livingstone, Philadelphia, Pa, USA, 2nd edition, 2007. View at Google Scholar
  56. R. I. Jakacki, “Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors: review of the literature,” Journal of Neurosurgery, vol. 102, no. 1, pp. 44–52, 2005. View at Google Scholar · View at Scopus
  57. T. E. Merchant, M.-H. Wang, and M.-H. Wang, “Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era,” International Journal of Radiation Oncology Biology Physics, vol. 36, no. 1, pp. 29–35, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. E. C. Halperin, “Impact of radiation technique upon the outcome of treatment for medulloblastoma,” International Journal of Radiation Oncology Biology Physics, vol. 36, no. 1, pp. 233–239, 1996. View at Google Scholar · View at Scopus
  59. C. Berger, P. Thiesse, A. Lellouch-Tubiana, C. Kalifa, A. Pierre-Kahn, and E. Bouffet, “Choroid plexus carcinomas in childhood: clinical features and prognostic factors,” Neurosurgery, vol. 42, no. 3, pp. 470–475, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. P. R. M. Thomas, M. Deutsch, and M. Deutsch, “Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation,” Journal of Clinical Oncology, vol. 18, no. 16, pp. 3004–3011, 2000. View at Google Scholar · View at Scopus
  61. D. A. Haas-Kogan, B. T. Missett, and B. T. Missett, “Radiation therapy for intracranial germ cell tumors,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 2, pp. 511–518, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Matsutani, “Pineal germ cell tumors,” Progress in neurological surgery, vol. 23, pp. 76–85, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. P. K. Duffner, M. E. Horowitz, and M. E. Horowitz, “Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors,” New England Journal of Medicine, vol. 328, no. 24, pp. 1725–1731, 1993. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Rutkowski, U. Bode, and U. Bode, “Treatment of early childhood medulloblastoma by postoperative chemotherapy alone,” New England Journal of Medicine, vol. 352, no. 10, pp. 978–986, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. K.-W. Shim, T.-G. Kim, and T.-G. Kim, “Treatment failure in intracranial primary germinomas,” Child's Nervous System, vol. 23, no. 10, pp. 1155–1161, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. L. E. Kun, “Acute lymphoblastic leukemia,” Seminars in Radiation Oncology, vol. 7, no. 3, pp. 185–194, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. C.-H. Pui and S. C. Howard, “Current management and challenges of malignant disease in the CNS in paediatric leukaemia,” The Lancet Oncology, vol. 9, no. 3, pp. 257–268, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. J. L. Franklin and J. Finlay, “Leukemias and lymphomas: treatment and prophylaxis of the central nervous system,” Current Treatment Options in Neurology, vol. 8, no. 4, pp. 335–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. M. E. Trigg, H. N. Sather, and H. N. Sather, “Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group,” Leukemia and Lymphoma, vol. 49, no. 6, pp. 1142–1154, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. D. P. Waber, B. L. Shapiro, and B. L. Shapiro, “Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01,” Cancer, vol. 92, no. 1, pp. 15–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. J. M. LeClerc, A. L. Billett, and A. L. Billett, “Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01,” Journal of Clinical Oncology, vol. 20, no. 1, pp. 237–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. D. P. Waber, L. B. Silverman, and L. B. Silverman, “Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity,” Journal of Clinical Oncology, vol. 22, no. 13, pp. 2701–2707, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. P. K. Duffner, “Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors,” Neurologist, vol. 10, no. 6, pp. 293–310, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. M. Schmiegelow, S. Lassen, H. S. Poulsen, U. Feldt-Rasmussen, K. Schmiegelow, H. Hertz, and J. Müller, “Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study,” Clinical Endocrinology, vol. 53, no. 2, pp. 191–197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. J. G. Douglas, J. L. Barker, R. G. Ellenbogen, and J. R. Geyer, “Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 4, pp. 1161–1164, 2004. View at Publisher · View at Google Scholar · View at PubMed
  76. T. E. Merchant, E. N. Kiehna, C. Li, X. Xiong, and R. K. Mulhern, “Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 5, pp. 1546–1554, 2005. View at Publisher · View at Google Scholar · View at PubMed
  77. T. E. Merchant, R. K. Mulhern, and R. K. Mulhern, “Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma,” Journal of Clinical Oncology, vol. 22, no. 15, pp. 3156–3162, 2004. View at Publisher · View at Google Scholar · View at PubMed
  78. R. K. Mulhern, T. E. Merchant, A. Gajjar, W. E. Reddick, and L. E. Kun, “Late neurocognitive sequelae in survivors of brain tumours in childhood,” Lancet Oncology, vol. 5, no. 7, pp. 399–408, 2004. View at Publisher · View at Google Scholar · View at PubMed
  79. R. Miralbell, A. Bleher, and A. Bleher, “Pediatric medulloblastoma: radiation treatment technique and patterns of failure,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 3, pp. 523–529, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. A. C. Paulino, A. Narayana, M. N. Mohideen, and S. Jeswani, “Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 46, no. 2, pp. 281–286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. T. E. Merchant, L. E. Kun, and L. E. Kun, “Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 3, pp. 782–787, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. E. Huang, B. S. Teh, and B. S. Teh, “Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity,” International Journal of Radiation Oncology Biology Physics, vol. 52, no. 3, pp. 599–605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. C. T. Lee, S. D. Bilton, and S. D. Bilton, “Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 2, pp. 362–372, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. G. E. Yuh, L. N. Loredo, and L. N. Loredo, “Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children,” Cancer Journal, vol. 10, no. 6, pp. 386–390, 2004. View at Google Scholar · View at Scopus
  85. W. H. St. Clair, J. A. Adams, and J. A. Adams, “Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 3, pp. 727–734, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. C.-H. Pui, D. Campana, and D. Campana, “Treating childhood acute lymphoblastic leukemia without cranial irradiation,” New England Journal of Medicine, vol. 360, no. 26, pp. 2730–2741, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. D. F. Nelson, K. L. Martz, and K. L. Martz, “Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315,” International Journal of Radiation Oncology Biology Physics, vol. 23, no. 1, pp. 9–17, 1992. View at Google Scholar · View at Scopus
  88. E. M. Bessell, A. López-Guillermo, and A. López-Guillermo, “Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments,” Journal of Clinical Oncology, vol. 20, no. 1, pp. 231–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. P. O'Brien, D. Roos, and D. Roos, “Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma,” Journal of Clinical Oncology, vol. 18, no. 3, pp. 519–526, 2000. View at Google Scholar · View at Scopus
  90. C. Schultz, C. Scott, and C. Scott, “Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88-06,” Journal of Clinical Oncology, vol. 14, no. 2, pp. 556–564, 1996. View at Google Scholar · View at Scopus
  91. L. M. DeAngelis, W. Seiferheld, S. Clifford Schold, B. Fisher, and C. J. Schultz, “Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10,” Journal of Clinical Oncology, vol. 20, no. 24, pp. 4643–4648, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Fisher, W. Seiferheld, and W. Seiferheld, “Secondary analysis of radiation therapy oncology group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma,” Journal of Neuro-Oncology, vol. 74, no. 2, pp. 201–205, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. P. M. P. Poortmans, H. C. Kluin-Nelemans, and H. C. Kluin-Nelemans, “High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962,” Journal of Clinical Oncology, vol. 21, no. 24, pp. 4483–4488, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. L. E. Abrey, J. Yahalom, and L. M. DeAngelis, “Treatment for primary CNS lymphoma: the next step,” Journal of Clinical Oncology, vol. 18, no. 17, pp. 3144–3150, 2000. View at Google Scholar · View at Scopus
  95. H. Pels, I. G. H. Schmidt-Wolf, and I. G. H. Schmidt-Wolf, “Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy,” Journal of Clinical Oncology, vol. 21, no. 24, pp. 4489–4495, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. T. Batchelor, K. Carson, and K. Carson, “Treatment of pimary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07,” Journal of Clinical Oncology, vol. 21, no. 6, pp. 1044–1049, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Hoang-Xuan, L. Taillandier, and L. Taillandier, “Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group,” Journal of Clinical Oncology, vol. 21, no. 14, pp. 2726–2731, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. A. M. P. Omuro, L. S. Ben-Porat, and L. S. Ben-Porat, “Delayed neurotoxicity in primary central nervous system lymphoma,” Archives of Neurology, vol. 62, no. 10, pp. 1595–1600, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. R. Lai, L. E. Abrey, M. K. Rosenblum, and L. M. DeAngelis, “Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study,” Neurology, vol. 62, no. 3, pp. 451–456, 2004. View at Google Scholar · View at Scopus
  100. L. E. Abrey, L. Ben-Porat, and L. Ben-Porat, “Primary central nervous system lymphoma: the memorial sloan-kettering cancer center prognostic model,” Journal of Clinical Oncology, vol. 24, no. 36, pp. 5711–5715, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. A. J. M. Ferreri, J.-Y. Blay, and J.-Y. Blay, “Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience,” Journal of Clinical Oncology, vol. 21, no. 2, pp. 266–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Aoyama, M. Tago, and M. Tago, “Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 5, pp. 1388–1395, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. E. L. Chang, J. S. Wefel, and J. S. Wefel, “A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone,” Neurosurgery, vol. 60, no. 2, pp. 277–283, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. H. Aoyama, H. Shirato, and H. Shirato, “Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial,” Journal of the American Medical Association, vol. 295, no. 21, pp. 2483–2491, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. S. M. Sawrie, B. L. Guthrie, and B. L. Guthrie, “Predictors of Distant Brain Recurrence for Patients With Newly Diagnosed Brain Metastases Treated With Stereotactic Radiosurgery Alone,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 1, pp. 181–186, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. A. K. Bhatnagar, J. C. Flickinger, D. Kondziolka, and L. D. Lunsford, “Stereotactic radiosurgery for four or more intracranial metastases,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 3, pp. 898–903, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. D. Kondziolka, A. Patel, L. D. Lunsford, A. Kassam, and J. C. Flickinger, “Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases,” International Journal of Radiation Oncology Biology Physics, vol. 45, no. 2, pp. 427–434, 1999. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Pirzkall, J. Debus, F. Lohr, M. Fuss, B. Rhein, R. Engenhart-Cabillic, and M. Wannenmacher, “Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases,” Journal of Clinical Oncology, vol. 16, no. 11, pp. 3563–3569, 1998. View at Google Scholar · View at Scopus
  109. D. Rades, J.-D. Kueter, D. Hornung, T. Veninga, P. Hanssens, S. E. Schild, and J. Dunst, “Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases,” Strahlentherapie und Onkologie, vol. 184, no. 12, pp. 655–662, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. M. K. Shehata, B. Young, and B. Young, “Stereotatic radiosurgery of 468 brain metastases ≤2 cm: implications for SRS dose and whole brain radiation therapy,” International Journal of Radiation Oncology Biology Physics, vol. 59, no. 1, pp. 87–93, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. J. M. Varlotto, J. C. Flickinger, A. Niranjan, A. Bhatnagar, D. Kondziolka, and L. D. Lunsford, “The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 4, pp. 1125–1132, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. D. Kondziolka, A. Niranjan, J. C. Flickinger, and L. D. Lunsford, “Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications,” American Journal of Clinical Oncology, vol. 28, no. 2, pp. 173–179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. E. L. Chang, J. S. Wefel, and J. S. Wefel, “Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial,” The Lancet Oncology, vol. 10, no. 11, pp. 1037–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. J. Li, S. M. Bentzen, M. Renschler, and M. P. Mehta, “Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function,” Journal of Clinical Oncology, vol. 25, no. 10, pp. 1260–1266, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. B. W. Corn, J. Moughan, and J. Moughan, “Prospective Evaluation of Quality of Life and Neurocognitive Effects in Patients With Multiple Brain Metastases Receiving Whole-Brain Radiotherapy With or Without Thalidomide on Radiation Therapy Oncology Group (RTOG) Trial 0118,” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 1, pp. 71–78, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. C. Nieder, A. Leicht, B. Motaref, U. Nestle, M. Niewald, and K. Schnabel, “Late radiation toxicity after whole-brain radiotherapy: the influence of antiepileptic drugs,” American Journal of Clinical Oncology, vol. 22, no. 6, pp. 573–579, 1999. View at Publisher · View at Google Scholar · View at Scopus
  117. J. S. Wefel, R. Lenzi, R. Theriault, A. U. Buzdar, S. Cruickshank, and C. A. Meyers, “'Chemobrain' in breast carcinoma? A prologue,” Cancer, vol. 101, no. 3, pp. 466–475, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  118. W. F. Regine, F. A. Schmitt, and F. A. Schmitt, “Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 5, pp. 1346–1352, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. A. Ghia, W. A. Tomé, S. Thomas, G. Cannon, D. Khuntia, J. S. Kuo, and M. P. Mehta, “Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 4, pp. 971–977, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. A. N. Gutiérrez, D. C. Westerly, and D. C. Westerly, “Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study,” International Journal of Radiation Oncology Biology Physics, vol. 69, no. 2, pp. 589–597, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. J. C. Marsh, A. M. Herskovic, B. T. Gielda, F. F. Hughes, T. Hoeppner, J. Turian, and R. A. Abrams, “Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 2, pp. 504–512, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. E. L. Kier, J. H. Kim, R. K. Fulbright, and R. A. Bronen, “Embryology of the human fetal hippocampus: Mr imaging, anatomy, and histology,” American Journal of Neuroradiology, vol. 18, no. 3, pp. 525–532, 1997. View at Google Scholar · View at Scopus
  123. A. Lautin, The Limbic Brain, Kluwer Academic/ Plenum, New York, NY, USA, 2001.
  124. P. S. Eriksson, E. Perfilieva, T. Björk-Eriksson, A.-M. Alborn, C. Nordborg, D. A. Peterson, and F. H. Gage, “Neurogenesis in the adult human hippocampus,” Nature Medicine, vol. 4, no. 11, pp. 1313–1317, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  125. M. L. Monje, S. Mizumatsu, J. R. Fike, and T. D. Palmer, “Irradiation induces neural precursor-cell dysfunction,” Nature Medicine, vol. 8, no. 9, pp. 955–962, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. M. L. Monje and T. Palmer, “Radiation injury and neurogenesis,” Current Opinion in Neurology, vol. 16, no. 2, pp. 129–134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. O. K. Abayomi, “Pathogenesis of irradiation-induced cognitive dysfunction,” Acta Oncologica, vol. 35, no. 6, pp. 659–663, 1996. View at Google Scholar · View at Scopus
  128. S. Mizumatsu, M. L. Monje, D. R. Morhardt, R. Rola, T. D. Palmer, and J. R. Fike, “Extreme sensitivity of adult neurogenesis to low doses of X-irradiation,” Cancer Research, vol. 63, no. 14, pp. 4021–4027, 2003. View at Google Scholar · View at Scopus
  129. J. Marsh, B. Gielda, A. Herskovic et al., “Sparing of the limbic circuit and pituitary during whole brain radiation therapy: a dosimetric study using helical tomotherapy,” submitted for publication.
  130. F. Hsu, H. Carolan, and H. Carolan, “Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1–3 brain metastases: a feasibility study using volumetric modulated Arc therapy,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 5, pp. 1480–1485, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. B. A. Reynolds and S. Weiss, “Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system,” Science, vol. 255, no. 5052, pp. 1707–1710, 1992. View at Google Scholar · View at Scopus
  132. P. Taupin and F. H. Gage, “Adult neurogenesis and neural stem cells of the central nervous system in mammals,” Journal of Neuroscience Research, vol. 69, no. 6, pp. 745–749, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. F. Doetsch, I. Caille, D. A. Lim, J. M. Garcia-Verdugo, and A. Alvarez-Buylla, “Subventricular zone astrocytes are neural stem cells in the adult mammalian brain,” Cell, vol. 97, no. 6, pp. 703–716, 1999. View at Publisher · View at Google Scholar · View at Scopus
  134. C. M. Morshead, B. A. Reynolds, and B. A. Reynolds, “Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells,” Neuron, vol. 13, no. 5, pp. 1071–1082, 1994. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Becker, “A computational principle for hippocampal learning and neurogenesis,” Hippocampus, vol. 15, no. 6, pp. 722–738, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. L. Wiskott, M. J. Rasch, and G. Kempermann, “A functional hypothesis for adult hippocampal neurogenesis: avoidance of catastrophic interference in the dentate gyrus,” Hippocampus, vol. 16, no. 3, pp. 329–343, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  137. J. B. Aimone, J. Wiles, and F. H. Gage, “Potential role for adult neurogenesis in the encoding of time in new memories,” Nature Neuroscience, vol. 9, no. 6, pp. 723–727, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  138. O. Arias-Carrión, N. Freundlieb, W. H. Oertel, and G. U. Höglinger, “Adult neurogenesis and Parkinson's disease,” CNS and Neurological Disorders—Drug Targets, vol. 6, no. 5, pp. 326–335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  139. J. Fallon, S. Reid, and S. Reid, “In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 26, pp. 14686–14691, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. O. Arias-Carrión, L. Verdugo-Díaz, A. Feria-Velasco, D. Millán-Aldaco, A. A. Gutiérrez, A. Hernández-Cruz, and R. Drucker-Colín, “Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions,” Journal of Neuroscience Research, vol. 78, no. 1, pp. 16–28, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. O. Arias-Carrión, S. Hernández-López, O. Ibañez-Sandoval, J. Bargas, A. Hernández-Cruz, and R. Drucker-Colín, “Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant,” Journal of Neuroscience Research, vol. 84, no. 7, pp. 1425–1437, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. G. U. Höglinger, P. Rizk, M. P. Muriel, C. Duyckaerts, W. H. Oertel, I. Caille, and E. C. Hirsch, “Dopamine depletion impairs precursor cell proliferation in Parkinson disease,” Nature Neuroscience, vol. 7, no. 7, pp. 726–735, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. I. J. Barani, L. W. Cuttino, and L. W. Cuttino, “Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 4, pp. 978–985, 2007. View at Publisher · View at Google Scholar · View at PubMed
  144. I. J. Barani, S. H. Benedict, and P.-S. Lin, “Neural stem cells: implications for the conventional radiotherapy of central nervous system malignancies,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 2, pp. 324–333, 2007. View at Publisher · View at Google Scholar · View at PubMed
  145. J. R. Fike, S. Rosi, and C. L. Limoli, “Neural precursor cells and central nervous system radiation sensitivity,” Seminars in Radiation Oncology, vol. 19, no. 2, pp. 122–132, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. G. Winocur, J. M. Wojtowicz, M. Sekeres, J. S. Snyder, and S. Wang, “Inhibition of neurogenesis interferes with hippocampus-dependent memory function,” Hippocampus, vol. 16, no. 3, pp. 296–304, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. R. Rola, J. Raber, A. Rizk, S. Otsuka, S. R. Vandenberg, D. R. Morhardt, and J. R. Fike, “Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice,” Experimental Neurology, vol. 188, no. 2, pp. 316–330, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. J. Raber, Y. Fan, Y. Matsumori, Z. Liu, P. R. Weinstein, J. R. Fike, and J. Liu, “Irradiation attenuates neurogenesis and exacerbates ischemia-induced deficits,” Annals of Neurology, vol. 55, no. 3, pp. 381–389, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  149. J. Raber, R. Rola, and R. Rola, “Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis,” Radiation Research, vol. 162, no. 1, pp. 39–47, 2004. View at Publisher · View at Google Scholar · View at Scopus
  150. T. M. Madsen, P. E. G. Kristjansen, T. G. Bolwig, and G. Wörtwein, “Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat,” Neuroscience, vol. 119, no. 3, pp. 635–642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  151. F. H. Gage, “Mammalian neural stem cells,” Science, vol. 287, no. 5457, pp. 1433–1438, 2000. View at Publisher · View at Google Scholar · View at Scopus
  152. M. L. Monje, H. Vogel, M. Masek, K. L. Ligon, P. G. Fisher, and T. D. Palmer, “Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies,” Annals of Neurology, vol. 62, no. 5, pp. 515–520, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. J. C. Marsh, R. H. Godbole, A. M. Herskovic et al., “Sparing of the neural stem cell compartment during whole brain radiation therapy: a dosimetric study using helical tomotherapy”.
  154. A. M. Herskovic, D. Han, J. Marsh et al., “Cognitive Sparing during Elective Brain Radiation: A Prospective Phase II Trial of Prophylactic Cranial Irradiation (PCI) for Limited Stage Small Cell Lung Cancer and Whole Brain Radiotherapy (WBRT) for Solitary Resected Brain Metastases With Selective Dosimetric Sparing of the Pituitary and Bilateral Hippocampus and Limbic Circuit Using Helical Tomotherapy,” Currently open at Rush University Medical Center, Chicago, Ill, USA.